Cargando…
Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study
BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Cana...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198791/ https://www.ncbi.nlm.nih.gov/pubmed/25278003 http://dx.doi.org/10.1186/1471-2458-14-1029 |
_version_ | 1782339788576129024 |
---|---|
author | Lim, W Ting Sears, Kim Smith, Leah M Liu, Guoyuan Lévesque, Linda E |
author_facet | Lim, W Ting Sears, Kim Smith, Leah M Liu, Guoyuan Lévesque, Linda E |
author_sort | Lim, W Ting |
collection | PubMed |
description | BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Canada’s largest publicly funded, school-based HPV vaccination program. METHODS: Using administrative health and immunization databases, we identified a population-based cohort of girls eligible for Ontario’s Grade 8 HPV vaccination program in the 2007/08-2009/10 program years who received at least one dose of the vaccine. We determined the number of doses received and calculated the percentage of girls that completed the three-dose series in Grade 8 and Grades 8–9. To assess on-time dosing, the number of days between doses 1–2, 2–3, and 1–3 was calculated and categorized (e.g., too short, on schedule, too long) based on the manufacturer’s recommendations. Analyses were also stratified by program year. RESULTS: We identified a cohort of 55,798 girls who initiated the vaccination series. Series completion was high in the Grade 8 window (81.8%) and increased by approximately 6% in Grade 9. Series completion was similar across the three program years. 70.8%, 98.5%, and 86.1% of girls were classified as ‘on schedule’ for dosing intervals 1–2, 2–3, and 1–3, respectively; 70.0% of girls received all three doses in perfect accordance with dosing recommendations. Stratification revealed that on-time dosing was highest in the first two years of the program (85.6% and 80.6%), but dropped to 42.1% in the 2009/10 year when H1N1 vaccination programs were prioritized. CONCLUSIONS: Our study demonstrates that delivery of the HPV vaccine through a free, school-based program is an effective method of ensuring high completion and on-time dosing, but may not be sufficient to guarantee high coverage. |
format | Online Article Text |
id | pubmed-4198791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41987912014-10-17 Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study Lim, W Ting Sears, Kim Smith, Leah M Liu, Guoyuan Lévesque, Linda E BMC Public Health Research Article BACKGROUND: Proper administration of the human papillomavirus (HPV) vaccine (three doses at 0, 2, and 6 months) will likely influence the vaccine’s effectiveness and the impact of vaccination programs on health outcomes. Therefore, we assessed HPV vaccine series completion and on-time dosing in Canada’s largest publicly funded, school-based HPV vaccination program. METHODS: Using administrative health and immunization databases, we identified a population-based cohort of girls eligible for Ontario’s Grade 8 HPV vaccination program in the 2007/08-2009/10 program years who received at least one dose of the vaccine. We determined the number of doses received and calculated the percentage of girls that completed the three-dose series in Grade 8 and Grades 8–9. To assess on-time dosing, the number of days between doses 1–2, 2–3, and 1–3 was calculated and categorized (e.g., too short, on schedule, too long) based on the manufacturer’s recommendations. Analyses were also stratified by program year. RESULTS: We identified a cohort of 55,798 girls who initiated the vaccination series. Series completion was high in the Grade 8 window (81.8%) and increased by approximately 6% in Grade 9. Series completion was similar across the three program years. 70.8%, 98.5%, and 86.1% of girls were classified as ‘on schedule’ for dosing intervals 1–2, 2–3, and 1–3, respectively; 70.0% of girls received all three doses in perfect accordance with dosing recommendations. Stratification revealed that on-time dosing was highest in the first two years of the program (85.6% and 80.6%), but dropped to 42.1% in the 2009/10 year when H1N1 vaccination programs were prioritized. CONCLUSIONS: Our study demonstrates that delivery of the HPV vaccine through a free, school-based program is an effective method of ensuring high completion and on-time dosing, but may not be sufficient to guarantee high coverage. BioMed Central 2014-10-03 /pmc/articles/PMC4198791/ /pubmed/25278003 http://dx.doi.org/10.1186/1471-2458-14-1029 Text en © Lim et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lim, W Ting Sears, Kim Smith, Leah M Liu, Guoyuan Lévesque, Linda E Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title_full | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title_fullStr | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title_full_unstemmed | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title_short | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
title_sort | evidence of effective delivery of the human papillomavirus (hpv) vaccine through a publicly funded, school-based program: the ontario grade 8 hpv vaccine cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198791/ https://www.ncbi.nlm.nih.gov/pubmed/25278003 http://dx.doi.org/10.1186/1471-2458-14-1029 |
work_keys_str_mv | AT limwting evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy AT searskim evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy AT smithleahm evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy AT liuguoyuan evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy AT levesquelindae evidenceofeffectivedeliveryofthehumanpapillomavirushpvvaccinethroughapubliclyfundedschoolbasedprogramtheontariograde8hpvvaccinecohortstudy |